ANETUMAB CORIXETAN THORIUM TH-227

UNII:	22OG9ZC9MN
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	ANETUMAB CORIXETAN THORIUM TH-227
GSRS Full Record:	22OG9ZC9MN i

2222980-98-3
BAY-2287411
BAY2287411
IMMUNOGLOBULIN G1, ANTI-(HUMAN MESOTHELIN) (HUMAN MONOCLONAL MF-T-IGG1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MF-T-IGG1 .LAMBDA.-CHAIN, DIMER, N6-(4-((4-(3-(BIS(2-(((1,2-DIHYDRO-3-(HYDROXY-.KAPPA.O)-1-METHYL-2-(OXO-.KAPPA.O)-4-PYRIDINYL)CARBONYL)AMINO)ETHYL)AMINO)-2-((BIS(2-(((1,2-DIHYDRO-3-(HYDROXY-.KAPPA.O)-1-METHYL-2-(OXO-.KAPPA.O)-4-PYRIDINYL)CARBONYL)AMINO)ETHYL)AMINO)METHYL)PROPYL)PHENYL)AMINO)-1,4-DIOXOBUTYL)-L-LYSINE COMPLEX WITH THORIUM-227TH

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ANETUMAB CORIXETAN THORIUM TH-227

Synonyms and Mappings

Resources